- Home
- AKTX vs UAMY Comparison
AKTX vs UAMY Comparison
Compare AKTX & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- UAMY
- Stock Information
- Founded
- AKTX N/A
- UAMY 1968
- Country
- AKTX United States
- UAMY United States
- Employees
- AKTX N/A
- UAMY N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- UAMY Metal Fabrications
- Sector
- AKTX Health Care
- UAMY Industrials
- Exchange
- AKTX Nasdaq
- UAMY Nasdaq
- Market Cap
- AKTX 41.8M
- UAMY 251.9M
- IPO Year
- AKTX N/A
- UAMY N/A
- Fundamental
- Price
- AKTX $1.17
- UAMY $2.22
- Analyst Decision
- AKTX
- UAMY Strong Buy
- Analyst Count
- AKTX 0
- UAMY 4
- Target Price
- AKTX N/A
- UAMY $3.38
- AVG Volume (30 Days)
- AKTX 27.5K
- UAMY 5.3M
- Earning Date
- AKTX 08-18-2025
- UAMY 08-08-2025
- Dividend Yield
- AKTX N/A
- UAMY N/A
- EPS Growth
- AKTX N/A
- UAMY N/A
- EPS
- AKTX N/A
- UAMY N/A
- Revenue
- AKTX N/A
- UAMY $18,865,900.00
- Revenue This Year
- AKTX N/A
- UAMY $270.45
- Revenue Next Year
- AKTX N/A
- UAMY $104.06
- P/E Ratio
- AKTX N/A
- UAMY N/A
- Revenue Growth
- AKTX N/A
- UAMY 97.46
- 52 Week Low
- AKTX $0.85
- UAMY $0.27
- 52 Week High
- AKTX $4.40
- UAMY $3.86
- Technical
- Relative Strength Index (RSI)
- AKTX 45.49
- UAMY 39.44
- Support Level
- AKTX $1.10
- UAMY $2.71
- Resistance Level
- AKTX $1.18
- UAMY $2.71
- Average True Range (ATR)
- AKTX 0.07
- UAMY 0.24
- MACD
- AKTX 0.00
- UAMY -0.07
- Stochastic Oscillator
- AKTX 53.25
- UAMY 24.14
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.